Epimedium contains icariin, a prenylated flavonoid that inhibits PDE5 — the SAME enzyme targeted by Viagra/sildenafil. In vitro, icariin is 80x weaker than sildenafil, but it also has testosterone-supportive and bone-density effects that PDE5 inhibitors don't have. Our research shows the mechanism is pharmacologically validated, but human clinical data for erectile dysfunction is almost nonexistent — two small Chinese studies with poor methodology. The name comes from a Chinese goatherd who noticed increased sexual activity in goats eating the plant. Despite the hilarious origin story, the science is real but the clinical evidence isn't there yet.
Icariin works through: (1) PDE5 inhibition — prevents cGMP breakdown in penile corpus cavernosum smooth muscle, maintaining NO-mediated vasodilation (same mechanism as sildenafil, but weaker); (2) eNOS activation — increases nitric oxide production; (3) testosterone support — stimulates Leydig cell steroidogenesis (cAMP pathway); (4) osteoblast stimulation — activates BMP-2/Smad signaling for bone formation; (5) neuroprotective — protects cavernous nerve from injury (relevant for post-prostatectomy ED). The prenyl group on icariin is essential for PDE5 inhibition — non-prenylated flavonoids are inactive.
Reviewed by the Scan Dose Research Team and Clinical Advisory Board | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.